Skip to Content

'
Miguel A. Rodriguez-Bigas, MD, FACS, FASCRS

Present Title & Affiliation

Primary Appointment

Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1982 University of Puerto Rico School of Medicine, San Juan, PR, MD, Medical Degree
1978 George Washington University, Washington, DC, BS, Chemistry

Postgraduate Training

1989-1990 Surgical Oncology Fellowship, Roswell Park Cancer Institute, Buffalo, NY
1988-1989 Head & Neck Surgery Fellowship, Roswell Park Cancer Institute, Buffalo, NY
1987-1988 Surgical Oncology Fellowship, Roswell Park Cancer Institute, Buffalo, NY
1983-1987 General Surgery Resident, University of Puerto Rico, University Hospital, Department of Surgery, San Juan, PR
1982-1983 General Surgery Internship, University of Puerto Rico, University Hospital, Department of Surgery, San Juan, PR

Board Certifications

2006 American Board of Surgery
1997 American Board of Surgery
1988 American Board of Surgery
1983 National Board of Medical Examiners,

Experience/Service

Academic Appointments

Associate Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1998-2001
Assistant Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1991-1998
Clinical Assistant Professor of Surgery, State University of New York at Buffalo, Buffalo, NY, 1990-1991

Administrative Appointments/Responsibilities

Chief, Division of Colorectal Surgery, Department of Surgery, Roswell Park Cancer Institute, Buffalo, NY, 1/2000-6/2001
Adjunct Faculty, Physician Assistant Program, DYouville College, Buffalo, NY, 5/1994-6/2001
Director, Hereditary Nonpolyposis Colorectal Cancer Registry, Roswell Park Cancer Institute, Buffalo, NY, 1/1993-6/2001
Director, Familial Polyposis Registry, Roswell Park Cancer Institute, Buffalo, NY, 1/1990-6/2001

Other Appointments/Responsibilities

Associate Member, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, 9/2007-present

Institutional Committee Activities

Member, The University of Texas M. D. Anderson Cancer Center, Faculty Senate, 1/2005-2008

Honors and Awards

2015 Best Doctors in America
2014 Best Doctors in America
2013 Best Doctors in America
2012 Best Doctors in America
2011 Best Doctors in America
2010 Best Doctors in America
2009 Best Doctors in America
2008 America's Top Oncologists, Guide to America's Top Oncologists
2008 Best Doctors in America
2008 Castle Connolly Top Doctor, Castle Connolly Medical Ltd.
2007 Best Doctors in America
2006 Best Doctors in America
2005 Best Doctors in America
2005 Outstanding Teacher Award, University of Texas M. D. Anderson Cancer Center
1999 Golden Apple Teaching Award, Best Teacher of the Year, Roswell Park Cancer Institute
1999 Outstanding Patient Care Award, Roswell Park Cancer Institute
1996 Ambassador, The Greater Buffalo Convention and Visitors Bureau
1996 Outstanding Young Men of America
1995 "40 Under Forty" Honor Roll, Buffalo's Business First, Western New York's Business Newspaper
1992 Citation's Who's Who Among Rising Young Americans in American Society and Business
1989-1990 Clinical Oncology Fellowship, The American Cancer Society
1988 Third Prize; Annual Residents and Fellows Essay Contest, Western New York Chapter of The American College of Surgeons

Professional Memberships

American Association for Cancer Research
Member, 1993-present
American Cancer Society
Member, 2003-present
Colorectal Cancer Advisory Committee, 2003-2009
American College of Surgeons
Fellow, 1993-present
American College of Surgeons Oncology Group
Audit Committee, 2002-2011
Colon and Rectal Organ Site Committee, 2000-2011
Member, 2000-2011
American College of Surgeons, Commission on Cancer
Executive Committee, 2007-2009
American Society for Gastrointestinal Endoscopy
Member, 1990-present
American Society of Clinical Oncology
Member, 1993-present
American Society of Colon and Rectal Surgeons
Fellow, 2001-present
Association for Academic Surgery
Member, 1989-present
Collaborative Group of the Americas on Inherited Colorectal Cancer
Executive Council Member at Large, 2001-2004
Member, 1998-present
Harris County Medical Society
Member, 2001-present
International Society for Hereditary Gastrointestinal Tumors (INSIGHT)
Council Member, 2011-2013
Co-Chair, 2009-2011
Council Member, 2003-2009
Society of American Gastrointestinal Endoscopic Surgeons
Member, 1991-present
Society of Surgical Oncology
Member, 1992-present
Society of University Surgeons
Member, 1998-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Carmack CL, Basen-Engquist K, Yuan Y, Greisinger A, Rodriguez-Bigas M, Wolff RA, Barker T, Baum G, Pennebaker JW. Feasibility of an expressive-disclosure group intervention for post-treatment colorectal cancer patients: Results of the healthy expressions study. Cancer 117(21):4993-5002, 11/1/2011. e-Pub 4/8/2011. PMID: 21480203.
2. Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM, Das P. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117(16):3713-22, 8/15/2011. e-Pub 2/15/2011. PMCID: PMC3266661.
3. You YN, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM. Prognostic Value of Quality of Life and Pain in Patients with Locally Recurrent Rectal Cancer. Ann Surg Oncol. e-Pub 12/4/2010. PMID: 21132391.
4. Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol 17(11):2863-9, 11/2010. e-Pub 6/15/2010. PMID: 20552409.
5. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210(6):934-41, 6/2010. PMID: 20510802.
6. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated Accelerated Radiotherapy for Rectal Cancer in Patients with Prior Pelvic Irradiation. Int J Radiat Oncol Biol Phys 77(1):60-5, 5/1/2010. e-Pub 8/19/2009. PMID: 19695792.
7. Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 76(3):824-30, 3/1/2010. e-Pub 5/21/2009. PMID: 19464823.
8. Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg 251(2):261-4, 2/2010. PMID: 19864936.
9. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, Delclos ME, Feig BW. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol 17(2):441-7, 2/2010. e-Pub 10/22/2009. PMID: 19847569.
10. Jasperson KW, Vu TM, Schwab AL, Neklason DW, Rodriguez-Bigas MA, Burt RW, Weitzel JN. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer 9(2):99-107, 2010. e-Pub 9/2009. PMID: 19731080.
11. De Jesus-Monge WE, Gonzalez-Keelan C, Zhao R, Hamilton SR, Rodriguez-Bigas M, Cruz-Correa M. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer 9(2):155-166, 2010. e-Pub 12/2009. PMID: 20012372.

Invited Articles

1. Rodriguez-Bigas MA, Chang GJ, Skibber JM. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am 19(4):847-59, 10/2010. PMID: 20883958.

Abstracts

1. You YN, Vilar E, Cuddy A, Wu A, Lynch PM, Eng C, Rodriguez-Bigas MA, Chang GJ. Are young adults with colorectal cancer doing enough to stay healthy?. AACR Annual Meeting 2015, 4/2015.
2. Burton-Chase AM, Parker WM, Polivka KM, Gritz ER, Amos CI, Frazier ML, Lu KH, Lynch PM, Rodriguez-Bigas MA, You YN, Peterson SK. Provider satisfaction in colorectal cancer patients: A comparison between Lynch syndrome and sporadic survivors. CGA-ICC 18th Annual Meeting, 9/2014.
3. Bailey CE, Rodriguez-Bigas MA, Tran Cao HA, Chang GJ, Feig B, Nguyen S, Skibber JM, You N. Persistent Functional Deficits and Symptoms among Long-Term Survivors of Colorectal Cancer Treated with Surgery and Multimodality Therapy: Differences by Age at Initial Diagnosis. Digestive Disease Week 2014, 5/2014.
4. Morris VK, Rashis A, Rodriguez-Bigas MA, Das P, Wolff RA, Chang GJ, Crane CH, Phillips J, Ohinata A, Roger J, Eng C. Human papillomavirus is associated with unique clinicopathologic features in patients with metastatic squamous cell carcinoma of the anal canal. 2014 Gastrointestinal Cancers Symposium, 1/2014.
5. Ernst R, Kaur H, Chang G, You YN, Rodriguez-Bigas M. Unraveling Colorectal Conference Conundrums using MRI. RSNA 2013, 12/2013.
6. Sanchez EV, Wu W, Bhatia G, Cuddy A, Mork MM, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Taggart MW, You YN. Can microsatellite status of colorectal cancer (CRC) be reliably assessed after neoadjuvant therapy?. 2013 ASCO Annual Meeting, 8/2013.
7. You NY, Bednarski B, Chang GJ, Khose S, Nguyen S, Feig B, Skibber J, Rodriguez-Bigas M. DNA Mismatch Repair Defects do not Account for the Majority of Newly Diagnosed Young-onset Colorectal Cancers. 2013 ASCRS Annual Meeting, 4/2013.
8. You YN, Chang GJ, Cormier J, Fieg BW, Rodriguez-Bigas M, Skibber JM. A Framework For Developing Quality Measures Of Survivorship Care In Colorectal Cancer. 2013 Cancer Survivorship Research Retreat, 2013.
9. You YN, Chang GJ, Feig BW, Skibber JM, Rodriguez-Bigas MA. DNA Mismatch Repair Defects Do Not Account for the Majority of Newly Diagnosed Young-Onset Colorectal Cancers. 2013 ASCRS Annual Meeting, 2013.
10. You YN, Sanchez EV, Slack R, Chang GJ, Nguyen ST, Cuddy A, Khose S, Wisniewski W, Bannon S, Mork MM, Lynch PM, Rodriguez-Bigas M. Lynch syndrome testing in ethnically diverse patients: Mutation spectrum and performance of prediction models. 2013 ASCO Annual Meeting, 2013.
11. Eng C, Rogrs J, Chang GJ, You YN, Das P, Rodriguez-Bigas MA, Ohinata A, Phillips J, Abbruzzese JL, Wolff RA. Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. 2012 ASCO Annual Meeting, 2012.
12. Abbott DE, Cantor SB, Rodriguez-Bigas MA, Chang GJ, Lynch PM, Feig BW, Skibber JM, You YN. Detecting hereditary nonpolyposis colorectal cancer syndrome (HNPCC) in patients with colorectal cancer (CRC): Optimal strategies at lower costs. 2012 Gastrointestinal Cancers Symposium, 2012.
13. Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-Caucasian patients. 2012 Gastrointestinal Cancers Symposium, 2012.
14. Chang GJ, Park IJ, Eng C, You YN, Kopetz S, Overman MJ, Rodriguez-Bigas MA, Skibber JM. Exploratory analysis of adjuvant chemotherapy benefits after preoperative chemoradiotherapy and radical resection for rectal cancer. 2012 ASCO Annual Meeting, 2012.
15. Park IJ, Eng C, You YN, Kopetz S, Rodriguez-Bigas MA, Overman MJ, Skibber JM, Chang GJ. Exploratory analysis of adjuvant chemotherapy effects after preoperative chemoradiotherapy and radical resection for rectal cancer. 2012 Gastrointestinal Cancers Symposium, 2012.
16. Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Hereditary Nonpolyposis Colrectal Cancer in NonCaucasian Patients. Society of Surgical, 2012.
17. Mitchell MP, Abboud M, Crane CH, Eng C, Chang GJ, Rodriguez-Bigas MA, Skibber JM, You YN, Beddar S, Krishnan S, Delclos ME, Das P. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience. 2012 Gastrointestinal Cancers Symposium, 2012.
18. Russell MC, Chian Y, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph Node Metastasis in Pateints with Early Pathologi T Stage Rectal Cancers: What Does Local Excision Leave Behind?. Society of Surgical Oncology, 65th Annual Cancer Symposium, 2012.
19. Russell, M, Chiang Y, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind?. 2012 Gastrointestinal Cancers Symposium, 2012.
20. Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggart MW, Skibber JM, Feig BW, You YN. Microsatellite high colorectal cancer: Does the underlying mechanism for instability matter?. 2012 Gastrointestinal Cancers Symposium, 2012.
21. Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggart MW, Skibber JM, Feig BW, You YN,. Microsatellite High Colorectal Cancer: Does the Underlying Mechanism for Instability Matter?. Society of Surgical Oncology, 65th Cancer Symposium, 2012.
22. Tzeng CD, Chang GJ, Curley SA, Vauthey JN, Ellis LM, Skibber JM, Feig BW, Abdalla EK, Aloia TA, You YN, Rodriguez-Bigas MA,. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis. 2012 Gastrointestinal Cancers Symposium, 2012.
23. Tzeng CD, Chang GJ, Curley SA, Vauthey JN, Ellis LM, Skibber JM, Feig BW, Abdalla EK, Aloia TA, You YN, Rodriguez-Bigas MA. Morbidity of Staged Proctectomy after Hepatectomy for Colorectal Cancer: A Matched Case-control Analysis. Society of Surgical Oncology, 65th Annual Cancer Syposium, 2012.
24. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Maru D, Munsell MF, Celmons MV, Kopetz S, Garrett CR, Shureiqi I, Krishnan S, Delclos ME, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial. 2012 Gastrointestinal Cancers Symposium, 2012.
25. Chang GJ, Hu CY, You YN, Eng C, Rodriguez-Bigas MA, Skibber JM. What determines adjuvant chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer?. 2012 Gastrointestinal Cancers Symposium, 2012.
26. Chagpar A, Cormier JN, Feig BW, Chang GJ, You YN, Rodriguez-Bigas MA, Skibber AM, Xing Y. Adherence to NCCN treatment guidelines for rectal cancer: Analysis of national practice patterns. 2011 ASCO Annual Meeting, 2011.
27. You YN, Xing B, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ, Cormier JN. Advanced-stage colon cancer prior to the screening age: Association with age, race, and insurance status. 2011 Gastrointestinal Cancers Symposium, 2011.
28. Eng C, Xing Y, You YN, Chang GJ, Das P, Phillips J, Wolff RA, Rodriguez-Bigas MA, Ohinata A, Crane CH. Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective. 2011 Gastrointestinal Cancers Symposium, 2011.
29. Abbott DE, Thomas AA, Rodriguez-Bigas MA, Skibber JM, Feig BW, You YN, Curley SA, Vauthey JN, Chang GJ. Economic Comparison of Simultaneous and Staged Resection for Synchronous Metastatic Colorectal Cancer. 97th Annual American College of Surgeons Clinical Congress, 2011.
30. Patel CB, Kattepogu KM, Park IJ, Eng C, Delclos ME, Feig BW, Crane CH, Skibber JM, Das P, Rodriguez-Bigas MA, Krishnan S, Chang GJ. Impact of preoperative radiation dose escalation on pathologic outcomes and radiation toxicity in locally advanced rectal cancer (LARC): A matched-pair analysis. 2011 ASCO Annual Meeting, 2011.
31. Chang GJ, Park IJ, You YN, Hu C, Hamilton SR, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Nguyen ST, Rodriguez-Bigas MA, Skibber JM. Neoadjuvant treatment response and outcomes in locally advanced rectal cancer: Establishing oncologic benchmarks. 2011 ASCO Annual Meeting, 2011.
32. Park IJ, Hu C, Rodriguez-Bigas MA, You YN, Skibber JM, Eng C, Wolff RA, Das P, Crane CH, Chang GJ. Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer. 2011 ASCO Annual Meeting, 2011.
33. Bowles TL, Hu C, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Cancers of the colon and rectum. Proc ASCO GI, 2010.
34. Chang G, Maru D, Afarwal A, Schlette E, Wolff R, Rodriguez-Bigas MA, You YN, Feig B, Kopetz S, Skibber J, Eng C. Histopathologic responses in primary tumors of patients with metastatic colorectal carcinoma after neoadjuvant systemic chemotherapy alone. ESMO Conference: 12th World Congress on Gastrointestinal Cancer, 2010.
35. You YN, Choi EA, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Crane CH, Das P, Chang GJ. Multimodal salvage therapy for locally recurrent and re-recurrent rectal cancer. Proc ASCO, 2010.
36. Tsa CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BF, Eng C, Delclos M, Krishnan S, Das P. Number of lymph nodes retrieved and prognosis among pathologically node-negative patients after preoperative chemoradiation therapy for rectal cancer. Proc ASCO, 2010.
37. You YN, Halim H, Chang GJ, Rodriguez-Bigas MA. Prognostic value of pain and quality of life in patients with locally recurrent rectal cancer. Proc SSO, 2010.
38. You YN, Saraiya D, Vu TM, Veerapong J, Lynch PM, Rodriguez-Bigas MA. Rectal cancer in patients with hereditary nonpolyposis colorectal cancer: surgical management and survival outcomes. 14th Annual Meeting of the Collaborative Group of the Americas on Colorectal Cancer, 2010.
39. Tanaka M, Bedrosian I, Chang GJ, You NY, Li D, Rodriguez-Bigas MA, Skibber JM, Abbruzzese JL, Eng C. Single nucleotide polymorphisms (SNPs) of hypoxia-related genes correlate with pathological complete response following neoadjuvant chemotherapy for locally advanced rectal cancer. Proc ASCO, 2010.
40. Ernst RD, Kaur H, You YN, Chang GJ, Rodriguez-Bigas MA. Structured reporting for MRI staging of rectal cancer. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2010.
41. Saraiya D, You YN, Askew RL, Vu TM, Lynch PM, Rodriguez-Bigas MA. The importance of tumor studies in the initial evaluation for Lynch Syndrome: a coparison of MMR postive and negative patients. 14th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer, 2010.
42. Eng C, Sethi S, Chang G, Rodriguez-Bigas M, Skibber J, Shen J, Zhu J, Ohinata A, Hamilton S, Li D. Proteomic analysis of potential tumor markers in AJCC stage II and III colon cancer. Proc ASCO, 2009.
43. Behm KT, Mathis KL, Shariq O, Bikhchandani J, Lynch H, Rodriguez-Bigas MA, Cuddy A, Dozois EJ, You Y. A Multi-institutional Study of Long-term Patient-reported Outcomes after Proctectomy vs. Proctocolectomy for Rectal Cancer in Patients with Lynch Syndrome. ASCRS 2016 Annual Scientific Meeting, Los Angeles, CA, April 30-May 4, 2016. Submitted.

Book Chapters

1. Orr WS, Pisters LL, Rodriguez-Bigas MA. Intraoperative Ureteral Injury. In: Gastrointestinal Surgery: Management of Complex Perioperative Complications. Ed(s) TM Pawlik, SK Maithel, NB Merchant. Springer: New York, 361-70, 2015. ISBN: 978-1-4939-2222-2.
2. Bannon S, Mork M, Rodriguez-Bigas MA. The young patient with colorectal cancer-genetic counseling discussion. In: Colorectal Cancer: Diagnosis and Management. Ed(s) Scholefield J, Eng C. Wiley Blackwell, 275-285, 2014.
3. Rodriguez-Bigas MA. Tratamiento de las metástasis hepáticas sincrónicas. In: Enfoque Multidisciplinario del Cáncer Colorectal. Ediciones Journal S.A. Argentina, 163-170, 2014.
4. Roses RE, Rodriguez-Bigas MA. The Management of Rectal Cancer. In: Current Surgical Therapy, 11th. Ed(s) Cameron JL, Cameron AM. Elsevier Sanders: Philadelphia, PA, 218-224, 2013.
5. Tan CH, Das P, Silberfein EJ, Rodriguez-Bigas MA, Iyer RB. Colorectal Cancer. In: Oncologic Imaging: A Multidisciplinary Approach, 2nd. Ed(s) Silverman PM: Philadelphia, PA, 267-286, 2012.
6. Bhadkamkar N, Crane CH, Rodriguez-Bigas MA, Kopetz S, Eng C. Colorectal Cancer. In: The MD Anderson Manual of Medical Oncology, 2nd. Ed(s) Kantarjian HM, Wolff RA, Koller CA. McGraw-Hill: New York, 549-588, 2011. ISBN: 978-0-07-170106-8.
7. Alberts AR, Citrin D, Rodriguez-Bigas MA, Das P. Colon, Rectal, and anal cancers. In: Cancer Management: A Multidisciplinary Approach. 12th. Ed(s) Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ. CMP Media, 2010.
8. Rodriguez-Bigas MA. Genotype phenotype correlation in familial adenomatous polyposis. In: Hereditary Colorectal Cancer. Ed(s) Rodriguez-Bigas MA, Cutait R, Lynch PM, Tomlinson I, Vasen HFA. Springer: New York, 197-202, 2010.
9. Rodriguez-Bigas, MA. Polipose associada ao MYH (PAM). In: Polipose Adenomatosa Familiar. Yendis: Sao Paulo, Brazil, 2010. ISBN: 978-85-7728-176-3.
10. Cutait R, Rodriguez-Bigas MA. Surgical management in Lynch Syndrome. In: Hereditary Colorectal Cancer. Ed(s) Rodriguez-Bigas MA, Cutait R, Lynch PM, Tomlinson I, Vasen HFA. Springer: New York, 301-310, 2010.

Books (edited and written)

1. Rodriguez-Bigas MA, Cutait R, Lynch PM, Tomlinson I, Vasen HFA. Hereditary Colorectal Cancer. In: M. D. Anderson Solid Tumor Oncology Series. Springer: New York, 2010. ISBN: 978-1-4419-6602-5.

Last updated: 8/16/2016